FDA
-
-
-
-
-
-
-
Prime Medicine gets FDA clearance for Wilson disease gene therapy trial
-
-
-
-
-
-
-
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
-
-
-
-
-
-
-
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
-
-
-
-
-
-
333,114 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


